Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

Tuberculosis

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bullous systemic lupus erythematosus: An uncommon manifestation in pediatric population.

Andes pediatrica : revista Chilena de pediatria·2021

Same author

[Suspected vascular ehlers danlos syndrome. Case report].

Revista medica de Chile·2018

Same author

[Effect of copper sulphate on the lung damage induced by chronic intermittent exposure to ozone].

Revista medica de Chile·2017

Same author

[Detection of HTLV-1 DNA in biopsies of Chilean patients with cutaneous T-cell lymphoma].

Revista medica de Chile·2014

Same author

[AA amyloidosis with cutaneous manifestations. Report of one case].

Revista medica de Chile·2012

Same author

[Sweet's syndrome associated with acute myeloid leukemia. Report of one case].

Revista medica de Chile·2012

Search research articles

Related Experiment Video

Updated: May 29, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

[Cutaneous tuberculosis: two case reports and review].

Marcela Concha R¹, Félix Fich S, Ricardo Rabagliati B

¹Departamento de Dermatología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile. Dermato@med.puc.cl

Revista Chilena De Infectologia : Organo Oficial De La Sociedad Chilena De Infectologia

|September 1, 2011

Summary

This summary is machine-generated.

Cutaneous tuberculosis, a rare skin infection from Mycobacterium tuberculosis, is rising due to HIV and immunosuppression. Diagnosis and classification pose challenges, requiring careful consideration of various clinical forms.

Related Experiment Videos

Last Updated: May 29, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Area of Science:

Dermatology
Infectious Diseases
Microbiology

Background:

Cutaneous tuberculosis (CTB) is an uncommon manifestation of Mycobacterium tuberculosis infection, accounting for approximately 1% of all tuberculosis cases.
CTB incidence is increasing, driven by the human immunodeficiency virus (HIV) epidemic and the widespread use of pharmacologic immunosuppression.
The clinical presentation of CTB is highly variable, influenced by the route of mycobacterial inoculation and the host's immune status.

Observation:

This report details two cases of cutaneous tuberculosis diagnosed at the Hospital Clínico de la Pontificia Universidad Católica de Chile.
The cases highlight the diagnostic complexities and classification challenges associated with cutaneous tuberculosis.
Varied clinical presentations underscore the importance of considering CTB in patients with relevant risk factors.

Findings:

Diagnosis of cutaneous tuberculosis can be challenging due to its diverse clinical manifestations.
Accurate classification of CTB subtypes is crucial for appropriate management.
The study emphasizes the need for a high index of suspicion in diagnosing CTB, particularly in immunocompromised individuals.

Implications:

Improved diagnostic strategies are needed to address the challenges in identifying cutaneous tuberculosis.
Understanding the varied clinical presentations is key for timely and accurate diagnosis.
Effective therapeutic approaches for cutaneous tuberculosis require careful consideration of the specific clinical form and patient's immune status.